Chengdu Zenitar Biomedical Technology Co., Ltd

This study tests a new drug, flonoltinib maleate, in people with intermediate- or high-risk myelofibrosis, a rare bone marrow disorder. The main goal is to see if the drug can shrink an enlarged spleen by at least 35% and reduce symptoms like pain and fatigue. About 105 participa…

This study tests a new oral drug, Flonoltinib maleate, in about 64 adults with intermediate- or high-risk myelofibrosis whose disease got worse or who could not tolerate JAK inhibitor therapy. The main goal is to see if the drug can shrink the spleen by at least 35%. Participants…

This study tests whether a daily pill called ZL-82 can reduce eczema symptoms in adults with moderate to severe atopic dermatitis. About 111 participants will take either the drug or a placebo for 16 weeks, with checkups every two weeks. The goal is to see if the drug improves sk…